26.07.2010 • Newssales and profitsAshland

Ashland Profit Nearly Triples as Sales Surge

Ashland, the chemical maker and Valvoline brand owner, said on Friday its quarterly profit nearly tripled as volumes and sales rallied across most of its business units. The company not only produces a wide range of chemicals, including industrial glues, but distributes chemicals for its rivals.

Its results are often a key barometer on the health of the overall chemical industry and by extension, the broader economy.

For the third quarter ended on June 30, Ashland posted net income of $148 million, or $1.85 per share, compared with $50 million, or 66 cents per share, a year earlier. Excluding one-time items, including a tax benefit, the company earned $1.22 per share. By that measure, analysts expected earnings of $1.13, according to Thomson Reuters I/B/E/S. Revenue rose 16% to $2.36 billion. Analysts expected $2.30 billion.

The Covington, Ky.-based company said the busy summer driving season helped fuel a 5% jump in sales at the consumer markets unit, which contains the Valvoline oil change business. Across the company, sales rose at three of its five units, with sales falling only slightly at the functional ingredients unit, which makes chemicals for paint, food and medical uses, and the water technologies unit, which supplies materials used in wastewater treatment. Sales in the chemical distribution unit rose 32.2%.

"As we consider the next few quarters, we anticipate sustained, gradual growth of the overall economy," Ashland Chief Executive Officer James O'Brien said in a statement. "We continue to see growth in both volume and sales."

Company

Ashland

5200 Blazer Parkway
43017 Dublin

Company contact







Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.